[ CAS No. 63160-12-3 ] {[proInfo.proName]}

Name: 63160-12-3|3-Phenyl-2-tosyl-1,2-oxaziridine|95%
Brand: Ambeed
SKU: A271160
Price: 129.0 USD
Availability: InStock
Rating: 92 (32 reviews)

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

DV 2D 3D

3d Animation Molecule Structure of 63160-12-3

Structure of 63160-12-3 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

For Research Only 120K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 63160-12-3 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 63160-12-3 ]

SDS Specification

Alternatived Products of [ 63160-12-3 ]

Product Details of [ 63160-12-3 ]

CAS No. :	63160-12-3	MDL No. :	MFCD22199989
Formula :	C₁₄H₁₃NO₃S	Boiling Point :	-
Linear Structure Formula :	CH₃C₆H₄SO₂(C₆H₅)CHNO	InChI Key :	SYTQRZCKINWJKR-UHFFFAOYSA-N
M.W :	275.32	Pubchem ID :	10967742
Synonyms :

Calculated chemistry of [ 63160-12-3 ] Expand+

Physicochemical Properties

Num. heavy atoms :	19
Num. arom. heavy atoms :	12
Fraction Csp3 :	0.14
Num. rotatable bonds :	3
Num. H-bond acceptors :	4.0
Num. H-bond donors :	0.0
Molar Refractivity :	74.77
TPSA :	58.06 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	Yes
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-5.93 cm/s

Lipophilicity

Log Po/w (iLOGP) :	2.66
Log Po/w (XLOGP3) :	2.88
Log Po/w (WLOGP) :	3.01
Log Po/w (MLOGP) :	2.7
Log Po/w (SILICOS-IT) :	1.87
Consensus Log Po/w :	2.62

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-3.63
Solubility :	0.0644 mg/ml ; 0.000234 mol/l
Class :	Soluble
Log S (Ali) :	-3.76
Solubility :	0.048 mg/ml ; 0.000174 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-4.34
Solubility :	0.0125 mg/ml ; 0.0000453 mol/l
Class :	Moderately soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	1.0 alert
Leadlikeness :	0.0
Synthetic accessibility :	3.36

Safety of [ 63160-12-3 ]

Signal Word:	Danger	Class:	8
Precautionary Statements:	P264-P270-P280-P301+P312+P330-P305+P351+P338+P310-P501	UN#:	1759
Hazard Statements:	H302-H318	Packing Group:	Ⅲ
GHS Pictogram:

Application In Synthesis of [ 63160-12-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 63160-12-3 ]
Downstream synthetic route of [ 63160-12-3 ]

[ 63160-12-3 ] Synthesis Path-Upstream 1~11

1
[ 51608-60-7 ]
[ 63160-12-3 ]

Yield	Reaction Conditions	Operation in experiment
96%	With C₂₆H₃₆N₄OS; 3-chloro-benzenecarboperoxoic acid In ethanol at -40℃; for 24 h;	General procedure: The corresponding imine (0.20 mmol), catalyst 2f (0.024 mmol) were dissolved in xylene (4.0 mL) at room temperature, and the mixture was stirred at room temperature for 5 min. Then, m-CPBA (purity 85percent, 0.24 mmol) was added at −40°C, stirring continued for the time indicated in Table 4, and the crude mixture was purified by flash chromatography on silica gel (petroleum ether/ethyl acetate=7:1) to provide the corresponding oxaziridines 3a–o.
95%	With N-benzyl-N,N,N-triethylammonium chloride; sodium hydrogencarbonate; 3-chloro-benzenecarboperoxoic acid In chloroform; water at 0℃; for 2 h;	To a mixed solution of saturated aqueous sodium bicarbonate (12 ml) and chloroform (10 ml), benzyltriethylammonium chloride (290 mg, 1.27 mmol) and N-benzylidene-4-toluenesulfonamide (Reference Example 144) (3.00 g, 11.6 mmol) were added, and a solution of m-chloroperbenzoic acid (2.58 g, 12.7 mmol) in chloroform (24 ml) was added dropwise thereto at 0°C with stirring. Thereafter, the resultant was stirred at the same temperature for 2 hours, and the mixture was gradually heated to room temperature. The reaction solution was extracted with chloroform, the organic layer was washed with saturated aqueous sodium bicarbonate, an aqueous solution of 5percent sodium bisulfite, and brine, dried (over potassium carbonate), and then concentrated under a reduced pressure. Hexane was added to the residue, the resulting slurry was filtered and washed, and a title compound (3.03 g,11.0 mmol, 95percent) was obtained as a white powder. ¹H-NMR (400 MHz, CDCl₃) δ: 2.50 (3H, s), 5.45 (1H, s), 7.40-7.47 (7H, m), 7.93 (2H, d, J = 8.4 Hz). ESI-MS: m/z = 276 (M+H⁺).

Reference： [1] Tetrahedron, 2016, vol. 72, # 4, p. 512 - 517
[2] Chemical Communications, 2010, vol. 46, # 6, p. 922 - 924
[3] Patent: EP2009006, 2008, A1, . Location in patent: Page/Page column 93-94
[4] Journal of Organic Chemistry, 2011, vol. 76, # 12, p. 4894 - 4904
[5] Chemistry - An Asian Journal, 2013, vol. 8, # 5, p. 883 - 887
[6] Organic Letters, 2016, vol. 18, # 19, p. 4940 - 4943
[7] Journal of the Chemical Society, Chemical Communications, 1977, p. 25 - 26
[8] Patent: JP2017/52729, 2017, A, . Location in patent: Paragraph 0029

2
[ 51608-60-7 ]
[ 63160-12-3 ]

Reference： [1] Organic Letters, 2005, vol. 7, # 24, p. 5493 - 5496
[2] Chemistry - A European Journal, 2015, vol. 21, # 29, p. 10530 - 10536

3
[ 6873-55-8 ]
[ 63160-12-3 ]

Reference： [1] Organic Letters, 2005, vol. 7, # 24, p. 5493 - 5496

4
[ 672-78-6 ]
[ 63160-12-3 ]

Reference： [1] Organic Letters, 2005, vol. 7, # 24, p. 5493 - 5496

5
[ 327040-08-4 ]
[ 63160-12-3 ]

Reference： [1] Organic Letters, 2005, vol. 7, # 24, p. 5493 - 5496

6
[ 70-55-3 ]
[ 63160-12-3 ]

Reference： [1] Chemistry - An Asian Journal, 2013, vol. 8, # 5, p. 883 - 887
[2] Patent: JP2017/52729, 2017, A,

7
[ 100-52-7 ]
[ 63160-12-3 ]

Reference： [1] Chemistry - An Asian Journal, 2013, vol. 8, # 5, p. 883 - 887
[2] Patent: JP2017/52729, 2017, A,

8
[ 100-52-7 ]
[ 70-55-3 ]
[ 63160-12-3 ]

Reference： [1] Journal of Organic Chemistry, 2011, vol. 76, # 12, p. 4894 - 4904
[2] Journal of Organic Chemistry, 2011, vol. 76, # 12, p. 4894 - 4904
[3] Patent: EP2009006, 2008, A1,

9
[ 55962-05-5 ]
[ 100-52-7 ]
[ 63160-12-3 ]

Reference： [1] Journal of Organic Chemistry, 2011, vol. 76, # 12, p. 4894 - 4904

10
[ 127-65-1 ]
[ 100-52-7 ]
[ 63160-12-3 ]

Reference： [1] Journal of Organic Chemistry, 2011, vol. 76, # 12, p. 4894 - 4904

11
[ 57272-54-5 ]
[ 63160-12-3 ]

Reference： [1] Journal of the Chemical Society, Chemical Communications, 1977, p. 25 - 26

[ 63160-12-3 ] Synthesis Path-Downstream 1~109

1
[ 51608-60-7 ]
[ 63160-12-3 ]

Yield	Reaction Conditions	Operation in experiment
96%	With C26H36N4OS; 3-chloro-benzenecarboperoxoic acid; In ethanol; at -40℃; for 24h;	General procedure: The corresponding imine (0.20 mmol), catalyst 2f (0.024 mmol) were dissolved in xylene (4.0 mL) at room temperature, and the mixture was stirred at room temperature for 5 min. Then, m-CPBA (purity 85%, 0.24 mmol) was added at -40C, stirring continued for the time indicated in Table 4, and the crude mixture was purified by flash chromatography on silica gel (petroleum ether/ethyl acetate=7:1) to provide the corresponding oxaziridines 3a-o.
95%	With N-benzyl-N,N,N-triethylammonium chloride; sodium hydrogencarbonate; 3-chloro-benzenecarboperoxoic acid; In chloroform; water; at 0℃; for 2h;	To a mixed solution of saturated aqueous sodium bicarbonate (12 ml) and chloroform (10 ml), benzyltriethylammonium chloride (290 mg, 1.27 mmol) and N-benzylidene-4-toluenesulfonamide (Reference Example 144) (3.00 g, 11.6 mmol) were added, and a solution of m-chloroperbenzoic acid (2.58 g, 12.7 mmol) in chloroform (24 ml) was added dropwise thereto at 0C with stirring. Thereafter, the resultant was stirred at the same temperature for 2 hours, and the mixture was gradually heated to room temperature. The reaction solution was extracted with chloroform, the organic layer was washed with saturated aqueous sodium bicarbonate, an aqueous solution of 5% sodium bisulfite, and brine, dried (over potassium carbonate), and then concentrated under a reduced pressure. Hexane was added to the residue, the resulting slurry was filtered and washed, and a title compound (3.03 g,11.0 mmol, 95%) was obtained as a white powder. 1H-NMR (400 MHz, CDCl3) delta: 2.50 (3H, s), 5.45 (1H, s), 7.40-7.47 (7H, m), 7.93 (2H, d, J = 8.4 Hz). ESI-MS: m/z = 276 (M+H+).
	With sodium hypochlorite pentahydrate; In water; acetonitrile; at 20℃; for 0.5h;	1.9743 g (12 mmol, 12 equivalents based on the substrate) of powder crystal of sodium hypochlorite pentahydrate (Nickel diazo pentahydrate, effective chlorine concentration 42%) was placed in a 50 mL recovery flask, and H 2 O 5. And dissolved in 5 mL to prepare a sodium hypochlorite aqueous solution.While confirming the pH of the aqueous solution with a pH meter, 12.5 M sodium hydroxide aqueous solution was added dropwise to adjust the pH to 14 and then cooled to 0 C. The imines (A1, 0.2590 g, 1 mmol) obtained in Synthesis Example 1 were placed in a separately prepared 30 mL flask and dissolved by adding 5 mL of water-containing acetonitrile.This acetonitrile solution was added to an aqueous sodium hypochlorite solution and stirred at 0 C. for 10 minutes.After lapse of 10 minutes, the reaction solution was brought to room temperature and further stirred for 20 minutes.After confirming that the raw material A1 (Rf = 0.45) had disappeared by thin layer chromatography (TLC, developing solvent Hexane: AcOEt = 3: 1, iodine coloration), H 2 O (50 mL) was added to the system , And extracted with AcOEt (30 mL × 3 times).The separated organic phase was washed with saturated aqueous sodium chloride solution.Anhydrous magnesium sulfate was put in the organic phase, dehydrated and dried, then it was removed by filtration operation, and the filtrate was distilled off with a rotary evaporator to give the oxaziridine compound (B1) (3-Phenyl-2-tosyl-1, 2-oxaziridine) as a white solid.As a by-product, benzaldehyde (C) was also obtained.

Reference： [1]Tetrahedron,2016,vol. 72,p. 512 - 517
[2]Chemical Communications,2010,vol. 46,p. 922 - 924
[3]Patent: EP2009006,2008,A1 .Location in patent: Page/Page column 93-94
[4]Journal of Organic Chemistry,2011,vol. 76,p. 4894 - 4904
[5]Chemistry - An Asian Journal,2013,vol. 8,p. 883 - 887
[6]Organic Letters,2016,vol. 18,p. 4940 - 4943
[7]Journal of the Chemical Society. Chemical communications,1977,p. 25 - 26
[8]Patent: JP2017/52729,2017,A .Location in patent: Paragraph 0029

2
[ 57272-54-5 ]
[ 63160-12-3 ]

Reference： [1]Journal of the Chemical Society. Chemical communications,1977,p. 25 - 26

3
[ 63160-12-3 ]
[ 70775-39-2 ]
[ 38455-36-6 ]

Reference： [1]Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry,1989,vol. 28,p. 685 - 686

4
[ 63160-12-3 ]
[ 70775-39-2 ]
[ 24395-14-0 ]

Reference： [1]Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry,1989,vol. 28,p. 685 - 686

5
[ 19340-68-2 ]
[ 63160-12-3 ]
[ 101067-78-1 ]
N-[(3R,4R)-1-(4-Methoxy-phenyl)-2-oxo-4-phenyl-azetidin-3-yl]-phenyl-methyl}-4-methyl-benzenesulfonamide [ No CAS ]

Reference： [1]Gazzetta Chimica Italiana,1995,vol. 125,p. 65 - 68
[2]Gazzetta Chimica Italiana,1995,vol. 125,p. 65 - 68

6
[ 51608-60-7 ]
[ 63160-12-3 ]

Reference： [1]Organic Letters,2005,vol. 7,p. 5493 - 5496
[2]Chemistry - A European Journal,2015,vol. 21,p. 10530 - 10536

7
[ 103-19-5 ]
[(bipy)NiCH₂-C(CH₃)-C(CH₃)-CH₂COO)] [ No CAS ]
[ 63160-12-3 ]

Reference： [1]Organic Letters,2005,vol. 7,p. 5493 - 5496

8
[ 6873-55-8 ]
[ 63160-12-3 ]

Reference： [1]Organic Letters,2005,vol. 7,p. 5493 - 5496

9
[ 672-78-6 ]
[ 63160-12-3 ]

Reference： [1]Organic Letters,2005,vol. 7,p. 5493 - 5496

10
[ 100-52-7 ]
SASRIN-maleidobenzoic acid resin [ No CAS ]
[ 63160-12-3 ]

Reference： [1]Organic Letters,2005,vol. 7,p. 5493 - 5496

11
[ 327040-08-4 ]
[ 63160-12-3 ]

Reference： [1]Organic Letters,2005,vol. 7,p. 5493 - 5496

12
[ 159176-94-0 ]
ethyl acetate n-hexane [ No CAS ]
ammonium chloride [ No CAS ]
[ 63160-12-3 ]
[ 159176-95-1 ]

Yield	Reaction Conditions	Operation in experiment
	With lithium hexamethyldisilazane; In tetrahydrofuran; ethyl acetate;	Step 5: Preparation of 4-hydroxy-2-(3-trifluoromethyl)phenyl-3-isoxazolidinone. Lithium bis(trimethylsilyl)amide (0.29 ml, 1M solution in tetrahydrofuran) was added slowly to a stirred solution of pure 2-(3-trifluoromethyl)phenyl-3-isoxazolidinone (0.06 g) in dry tetrahydrofuran (5 ml), maintaining the temperature below -75 C. The mixture was stirred for ten minutes at -78 C, allowed to warm to -25 C., recooled to -78 C., then treated with N(4-toluenesulphonyl)-3-phenyloxaziridine (0.08 g, prepared as described in J. Org. Chem., 1988, 53, 2087). It was stirred at -78 C. for a further one hour, allowed to warm to room temperature, poured on to saturated aqueous ammonium chloride solution and extracted with ethyl acetate. The extracts were washed with brine, dried over magnesium sulphate and evaporated under reduced pressure. The residue was chromatographed on silica, using hexane-ethyl acetate (3:1) then ethyl acetate as eluants, to give a pale yellow solid (0.05 g) comprising a mixture of the title compound and toluene p-sulphonamide. This material can be used directly for carbamoylation and the t-butylcarbamate readily separated from toluene p-sulphonamide. 1 H NMR (CDCl3): title compound signals only: delta 4.0(1H,broad s), 4.35(1H,t), 4.8(1H,t), 4.95(1H,t), 7.5(2H,m), 7.95(2H,m).

Reference： [1]Patent: US5856273,1999,A

13
[ 20452-67-9 ]
[ 63160-12-3 ]
[ 1258406-57-3 ]
C₂₄H₂₃NO₄S [ No CAS ]
C₂₄H₂₃NO₄S [ No CAS ]
C₂₄H₂₃NO₄S [ No CAS ]

Reference： [1]Angewandte Chemie - International Edition,2010,vol. 49,p. 8412 - 8416

14
[ 55962-05-5 ]
[ 100-52-7 ]
[ 63160-12-3 ]

Reference： [1]Journal of Organic Chemistry,2011,vol. 76,p. 4894 - 4904

15
[ 127-65-1 ]
[ 100-52-7 ]
[ 63160-12-3 ]

Reference： [1]Journal of Organic Chemistry,2011,vol. 76,p. 4894 - 4904

16
[ 100-52-7 ]
[ 70-55-3 ]
[ 63160-12-3 ]

Reference： [1]Journal of Organic Chemistry,2011,vol. 76,p. 4894 - 4904
[2]Journal of Organic Chemistry,2011,vol. 76,p. 4894 - 4904
[3]Patent: EP2009006,2008,A1
[4]Journal of Organic Chemistry,2019,vol. 84,p. 4282 - 4293

17
[ 1339939-33-1 ]
[ 63160-12-3 ]
[ 1339939-34-2 ]
C₃₀H₃₁NO₇S₂ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
76%; 12%		Potassium hexamethyldisilazide (KHMDS; 0.20 mL of a 1.6 M solution in toluene, 0.30 mmol) in tetrahydrofuran (5 mL) was stirred and cooled to -78 C before a solution of the foregoing hexenoate 50 (85 mg, 0.20 mmol) in tetrahydrofuran (1 mL) was added dropwise. The resulting orange solution was stirred for 20 min then a solution of <strong>[63160-12-3]2-(4-toluenesulfonyl)-3-phenyloxaziridine</strong> 51 (78 mg, 0.30 mmol)refPreviewPlaceHolder28 was added. After a further 20 min at this temperature, saturated aqueous ammonium chloride (10 mL) was added, the resulting mixture warmed to ambient temperature, the layers separated and the aqueous layer extracted with ether (2×10 mL). The combined organic solutions were dried, filtered and evaporated. Column chromatography of the residue separated the hydroxy-ester52 (68 mg, 76%) as a pale yellow oily solid and a 3:1 mixture of diastereoisomers which showed: 1H NMR (400 MHz, CDCl3): delta=(major isomer) 7.78 (d, J=8.0 Hz, 1H, 7'-H), 7.55 (d, J=8.2 Hz, 2H, 2× ArH), 7.40-7.36 (m, 2H, 2'- and 4'-H), 7.19 (d, J=8.2 Hz, 2H, 2× ArH), 7.15-7.10 (m, 2H, 5'- and 6'-H), 5.43 (d, J=9.5 Hz, 1H, 4-H), 4.29 (d, J=3.8 Hz, 1H, 2-H), 4.08 (dd, J=9.5, 3.8 Hz, 1H, 3-H), 3.83-3.78 (m, 2H, OCH2), 2.14 (s, 3H, ArMe), 1.59 (s, 3H, Me), 1.53 (s, 3H, Me), 1.11 (t, J=7.1 Hz, 3H, CH2CH3); (minor isomer) 7.79 (d, J=8.1 Hz, 1H, 7'-H), 7.60 (d, J=8.2 Hz, 2H, 2× ArH), 7.40-7.36 (m, 2H, 2'- and 4'-H), 7.19 (d, J=8.2 Hz, 2H, 2× ArH), 7.15-7.10 (m, 2H, 5'- and 6'-H), 5.33 (d, J=9.3 Hz, 1H, 4-H), 4.36 (d, J=3.0 Hz, 1H, 2-H), 3.99 (dd, J=9.3, 3.0 Hz, 1H, 3-H), 3.83-3.78 (m, 2H, OCH2), 2.14 (s, 3H, ArMe), 1.58 (s, 3H, Me), 1.51 (s, 3H, Me), 0.85 (t, J=7.1 Hz, 3H, CH2CH3); 13C NMR (100 MHz, CDCl3): delta=(major isomer) 178.3 (CO), 150.4 (s), 143.8 (s), 134.8 (s), 129.9 (s), 129.8 (d), 128.8 (d), 127.0 (s), 126.7 (d), 124.7 (d), 122.3 (d), 119.6 (d), 113.7 (d), 73.7 (2-CH), 61.7 (OCH2), 39.5 (3-CH), 25.9 (q), 21.6 (q), 18.2 (q), 13.9 (q); (minor isomer) 177.2 (CO), 149.1 (s), 143.7 (s), 134.1 (s), 129.7 (s), 129.2 (d), 128.5 (d), 127.1 (s), 126.9 (d), 124.7 (d), 122.3 (d), 119.8 (d), 115.1 (d), 73.1 (2-CH), 61.9 (OCH2), 39.4 (3-CH), 26.0 (q), 21.6 (q), 18.3 (q), 14.1 (q) (two resonances obscured); IR (CHCl3): numax=3316, 2919, 1730, 1447, 1369 cm-1; m/z [APCI] 442 (M++H, 100%); HRMS: m/z: calcd for C24H28NO5S: 442.1683; found: 442.1685 [M+H]+.

Reference： [1]Tetrahedron,2011,vol. 67,p. 8515 - 8528

18
[ 5874-61-3 ]
[ 63160-12-3 ]
(S,S)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
N-(5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)benzamide [ No CAS ]
[ 1445979-83-8 ]
[ 1445979-84-9 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029
[2]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

19
[ 5874-61-3 ]
[ 63160-12-3 ]
(S,S)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
N-(5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)benzamide [ No CAS ]
[ 1445979-84-9 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

20
[ 5874-61-3 ]
[ 63160-12-3 ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
N-(5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)benzamide [ No CAS ]
N-(((4-benzyl-5-oxo-2-phenyl-4,5-dihydrooxazol-4-yl)oxy)(phenyl)methyl)-4-methylbenzenesulfonamide [ No CAS ]
[ 1445979-83-8 ]
[ 1445979-84-9 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

21
[ 5874-61-3 ]
[ 63160-12-3 ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
N-(5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)benzamide [ No CAS ]
[ 1445979-83-8 ]
[ 1445979-84-9 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

22
[ 5874-61-3 ]
[ 63160-12-3 ]
N-(5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)benzamide [ No CAS ]
[ 1445979-83-8 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

23
[ 5874-61-3 ]
[ 63160-12-3 ]
(S,S)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
N-(5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)benzamide [ No CAS ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

24
[ 5874-61-3 ]
[ 63160-12-3 ]
(S,S)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
[ 1445979-83-8 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

25
[ 5874-61-3 ]
[ 63160-12-3 ]
N-(5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)benzamide [ No CAS ]
N-(5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)benzamide [ No CAS ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

26
[ 5874-61-3 ]
[ 63160-12-3 ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
[ 1445979-83-8 ]
[ 1445979-84-9 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

27
[ 63160-12-3 ]
[ 1445980-17-5 ]
[ 1445979-84-9 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029
[2]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029
[3]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029
[4]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029
[5]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029
[6]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

28
[ 63160-12-3 ]
1-(8b-methyl-2-phenyl-1-tosyl-1H-oxazolo[5,4-b]indol-4(2H,3aH,8bH)-yl)ethanone [ No CAS ]
1-(8b-methyl-2-phenyl-1-tosyl-1H-oxazolo[5,4-b]indol-4(2H,3aH,8bH)-yl)ethanone [ No CAS ]

29
[ 63160-12-3 ]
[ 1039660-92-8 ]

30
[ 63160-12-3 ]
[ 1445979-84-9 ]

31
[ 1236384-34-1 ]
[ 63160-12-3 ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
N-((2R,5R)-5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)-2-chlorobenzamide [ No CAS ]
[ 1445979-99-6 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

32
[ 1236384-35-2 ]
[ 63160-12-3 ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
N-((2R,5R)-5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)-3-chlorobenzamide [ No CAS ]
[ 1445980-00-6 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

33
[ 1236384-36-3 ]
[ 63160-12-3 ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
N-((2R,5R)-5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)-4-methylbenzamide [ No CAS ]
[ 1445980-02-8 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

34
[ 1273331-99-9 ]
[ 63160-12-3 ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
N-((2R,5R)-5-benzyl-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)-3,5-dimethylbenzamide [ No CAS ]
[ 1445980-03-9 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

35
[ 66421-85-0 ]
[ 63160-12-3 ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
C₃₀H₂₅N₃O₇S [ No CAS ]
[ 1445980-06-2 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

36
[ 24486-16-6 ]
[ 63160-12-3 ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
[ 1445980-04-0 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

37
[ 101693-51-0 ]
[ 63160-12-3 ]
(R,R)-3-phenyl-2-tosyl-1,2-oxaziridine [ No CAS ]
N-((2S,5S)-5-((1H-indol-3-yl)methyl)-4-oxo-2-phenyl-3-tosyloxazolidin-5-yl)benzamide [ No CAS ]
[ 1445980-05-1 ]

Reference： [1]Journal of the American Chemical Society,2013,vol. 135,p. 10026 - 10029

38
[ 63160-12-3 ]
[ 63160-12-3 ]
[ 6971-74-0 ]

Reference： [1]Chemical Science,2014,vol. 5,p. 3524 - 3527

39
C₁₇H₂₁NO [ No CAS ]
[ 63160-12-3 ]
C₃₁H₃₄N₂O₅S [ No CAS ]

Reference： [1]Chemistry - An Asian Journal,2013,vol. 8,p. 883 - 887

40
C₁₄H₁₇NO₂ [ No CAS ]
[ 63160-12-3 ]
C₂₇H₂₆N₂O₄S [ No CAS ]

Reference： [1]Chemistry - An Asian Journal,2013,vol. 8,p. 883 - 887

41
[ 70-55-3 ]
[ 63160-12-3 ]

Reference： [1]Chemistry - An Asian Journal,2013,vol. 8,p. 883 - 887
[2]Patent: JP2017/52729,2017,A

42
[ 100-52-7 ]
[ 63160-12-3 ]

Reference： [1]Chemistry - An Asian Journal,2013,vol. 8,p. 883 - 887
[2]Patent: JP2017/52729,2017,A

43
2-(4-(trifluoromethyl)phenyl)acetic anhydride [ No CAS ]
[ 63160-12-3 ]
2-phenyl-3-tosyl-5-(4-(trifluoromethyl)phenyl)oxazolidin-4-one [ No CAS ]
2-phenyl-3-tosyl-5-(4-(trifluoromethyl)phenyl)oxazolidin-4-one [ No CAS ]